CONDUIT PHARMACEUTICALS INC(NASDAQ:CDT) stock News

CDT Latest News, Press Relases and Analysis

All

Press Releases

14 days ago - By: Conduit Pharmaceuticals

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

15 days ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

15 days ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

2 months ago - By: Benzinga - Mentions: MBRX NEOG CLRB NCNA ...

12 Health Care Stocks Moving In Wednesday's Intraday Session

2 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

2 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

2 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

3 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Announces Leadership Changes

2 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

2 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

3 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program

2 months ago - By: Benzinga - Mentions: EVO RAPT ONCO ALTS ...

12 Health Care Stocks Moving In Friday's Intraday Session

2 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

2 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

2 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

2 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

2 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

2 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

2 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

3 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Announces Leadership Changes

3 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

3 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

3 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program

4 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization

4 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization

4 months ago - By: Conduit Pharmaceuticals

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

4 months ago - By: Conduit Pharmaceuticals

CONDUIT PHARMACEUTICALS INC (CDT) Stock News

CDT Latest News, Press Relases and Analysis